Why the study?
To evaluate plasma glycoprotein profiles as metabolic and inflammatory biomarkers underlying PCOS and its association with inflammation and obesity.
Do 1H-NMR-derived glycoprotein profiles identify low-grade chronic inflammation in women with PCOS independently of obesity?
Do 1H-NMR-derived glycoprotein profiles identify low-grade chronic inflammation in women with PCOS independently of obesity?
1H-NMR-derived glycoprotein profiles, specifically the height-to-width ratios of GlycA and GlycB, may serve as novel, obesity-independent biomarkers of low-grade chronic inflammation in women with PCOS.
Answers are grounded in this paper and cite their sources.
Glycoprotein ratios may identify obesity-independent inflammation in PCOS; hypothesis-generating and requires prospective validation before clinical use.
The polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting women in reproductive age. Obesity and low-grade chronic inflammation are frequently associated with PCOS. Recently, proton nuclear magnetic resonance ( 1 H-NMR)-derived glycoprotein profiles have emerged as potential biomarkers that reflect systemic inflammation in type 2 diabetes, obesity, and other pathological processes. The aim of this work is to study plasma glycoprotein profiles as metabolic/inflammatory biomarkers underlying PCOS and its association with inflammation and obesity. We used 1 H-NMR spectroscopy to study five glycoprotein variables, namely GlycA, GlycB, and GlycF and the height-to-width ( H / W ) ratio of GlycA and GlycB, in 17 women with PCOS (9 non-obese and 8 obese), 17 control women (9 non-obese and 8 obese), and 19 healthy men (10 non-obese and 9 obese). H / W ratios of GlycA and GlycB, but not glycoprotein areas, were specifically associated with PCOS independently of obesity. When considered as a whole, obese subjects presented higher GlycA, GlycB, and GlycF areas and higher H / W GlycA and GlycB ratios than their non-obese counterparts. All glycoprotein variables were associated with hsCRP, IL-6, and TNF-α, showing different correlations among PCOS, women, and men. Our present exploratory results suggest that 1 H-NMR-derived glycoprotein profiles might serve as novel diagnostic markers of low-grade chronic inflammation in women with PCOS.
No takes yet. Share an insight, caveat, or question.
Fuertes-Martín et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: